Human immunodeficiency virus

Human immunodeficiency virus Human immunodeficiency virus is a member of the Retroviridae family that infects humans and causes progressive immunodeficiency leading to AIDS. Discovered in the early 1980s amid clusters of illness in Los Angeles, New York City, and San Francisco, the virus has shaped responses by institutions such as the World Health Organization, Centers for Disease Control and Prevention, and UNAIDS. Research involving laboratories at the Pasteur Institute, National Institutes of Health, and universities like Harvard University and University of Oxford established its molecular biology and clinical management.

Virology and Structure

The virus is an enveloped RNA virus of the genus Lentivirus within Retroviridae, encoding enzymes including reverse transcriptase, integrase, and protease that mediate replication. Its virion exhibits surface glycoproteins derived from the env gene—notably gp120 and gp41—that bind host receptors such as CD4 and chemokine coreceptors originally characterized in studies involving the Rockefeller University and Stanford University. The viral genome organization and regulatory proteins (Tat, Rev, Nef) were elucidated in collaborations between laboratories at the Institut Pasteur and University of California, San Francisco. Structural biology using techniques developed at Max Planck Institute and European Molecular Biology Laboratory resolved envelope and capsid architectures guiding antiretroviral design.

Transmission and Pathogenesis

Transmission occurs via blood, sexual contact, mother-to-child transmission during childbirth or breastfeeding, and transfusion-related exposures documented in historical outbreaks in Haiti, Raymond Dart-era studies, and surveillance by the Pan American Health Organization. Pathogenesis centers on infection and depletion of CD4+ T lymphocytes primarily in lymph nodes and gut-associated lymphoid tissue, with immune activation pathways described in studies at the Karolinska Institute and Imperial College London. Viral reservoirs in long-lived cells, latency mechanisms examined at Cold Spring Harbor Laboratory and Weill Cornell Medicine, and viral evolution under selective pressure from host immunity and antiretroviral therapy have parallels to work on viral quasispecies at Los Alamos National Laboratory. Cofactors influencing transmission risk have been studied in population cohorts from South Africa, Uganda, Brazil, and Thailand.

Clinical Manifestations and Diagnosis

Acute infection often presents as a mononucleosis-like syndrome observed in clinical series from Johns Hopkins University and Mount Sinai Health System, followed by a chronic asymptomatic phase and eventual opportunistic infections defining AIDS, as catalogued by the World Health Organization and clinical manuals used at Mayo Clinic and Cleveland Clinic. Opportunistic pathogens include Pneumocystis jirovecii, Mycobacterium tuberculosis, Candida albicans, and oncogenic viruses such as Kaposi's sarcoma-associated herpesvirus and Epstein–Barr virus that produce presentations described in oncology centers like Memorial Sloan Kettering Cancer Center. Diagnostic testing with fourth-generation antigen/antibody assays and nucleic acid tests was standardized through collaborations involving the Food and Drug Administration and diagnostic manufacturers validated in trials at Oxford University Hospitals.

Prevention and Treatment

Prevention strategies include condom promotion campaigns pioneered in programs like those run by Planned Parenthood, needle-exchange initiatives evaluated in policy work at Brown University, antenatal screening implemented by ministries of health in Botswana and Rwanda, and pre-exposure prophylaxis regimens recommended in guidelines from World Health Organization and Centers for Disease Control and Prevention. Antiretroviral therapy (ART) combines nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, and integrase strand transfer inhibitors, developed by pharmaceutical collaborations including GlaxoSmithKline, Gilead Sciences, and Merck & Co. and tested in landmark trials such as those coordinated by the International AIDS Society and ACTG. Cure research spans gene-editing efforts at Sanger Institute and stem-cell transplant cases reported in publications associated with University College London and Hannover Medical School.

Epidemiology and Public Health Impact

Global epidemiological trends tracked by UNAIDS and World Health Organization show concentrated epidemics in regions including sub-Saharan Africa, with national responses by governments of South Africa, Kenya, and Brazil shaping outcomes through programs supported by the Global Fund and PEPFAR. Stigma, discrimination, and legal frameworks affecting key populations have been addressed in reports by Amnesty International, Human Rights Watch, and policy analyses from Harvard Kennedy School. Economic and demographic modeling of epidemic trajectories has involved institutions such as the London School of Economics and Johns Hopkins Bloomberg School of Public Health, informing vaccination, testing, and treatment scale-up campaigns executed with partners like Clinton Health Access Initiative and Bill & Melinda Gates Foundation.

Category:VirusesCategory:Retroviridae